Evidence map›Paper›PMID 41602039›Full record

ArticleFrontiers in public health2025

Frequency-aligned loss and spectral filtering improve long-range influenza forecasting.

Tianyi Feng, Chunyan Luo, Yu Huang

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tianyi FengDepartment of Rehabilitation, West China Hospital Sichuan University Jintang Hospital, Jintang First People's Hospital, Chengdu, China.
Chunyan LuoJilin Institute of Physical Education, Changchun, China.
Yu HuangDepartment of Rehabilitation, West China Hospital Sichuan University Jintang Hospital, Jintang First People's Hospital, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-horizon forecasts of seasonal influenza remain limited by (i) rapid error growth beyond a few weeks, (ii) entanglement of persistent seasonal cycles with transient outbreaks, and (iii) training objectives that ignore strong autocorrelation in future incidence labels. Methods: We introduce a frequency-aware pipeline that couples a Spectral Adaptive Filtering Network with a Frequency-Aligned Direct Loss. The backbone first isolates stable global spectral bands and then builds window-specific cross-covariate filters to capture transient events; this convex loss function simultaneously supervises prediction results in both the time domain and the approximated decorrelated frequency domain, effectively reducing bias caused by autocorrelation without sacrificing point accuracy. Results: On 49 US states (2010-2020), 10 HHS and 9 Census regions (2002-2020), the proposed model lowers MSE by 6-15% and MAE by 2-20% at 24-week horizons vs. six recent baselines while maintaining interpretable band-pass responses that match annual and semi-annual epidemiological periodicities. Ablation and sensitivity analyses confirm that joint time-frequency supervision and dual static-dynamic filtering are both required for peak performance. Conclusions: Explicit spectral decomposition coupled with autocorrelation-aware training offers a principled route to stable, interpretable long-range influenza forecasting; the modular objective can be plugged into alternative architectures to gain similar error reductions.

Indexed as

Influenza, HumanDisease OutbreaksForecastingHumansPrediction AlgorithmsSeasonsUnited Statesfrequency-aligned losslong-horizon epidemic predictionlong-horizon forecastseasonal-influenza forecastingspectral adaptive filtering

Identifiers

PMID41602039
PMCPMC12832692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.